University at Buffalo Clinical and Translational Research Center
Buffalo, New York, United States
Public university in Buffalo, New York
875 Ellicott St, Buffalo, NY 14203
About University at Buffalo Clinical and Translational Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
2
Intercept Pharmaceuticals
2
Pfizer
2
Presidio Pharmaceuticals, Inc.
2
Eli Lilly and Company
1
Genfit
1
IMS HEALTH GmbH & Co. OHG
1
NeXtGen Biologics, Inc.
1
Pharmena North America
1
Protalex, Inc.
1
State University of New York at Buffalo
1
Clinical Trials at University at Buffalo Clinical and Translational Research Center
During the past decade, University at Buffalo Clinical and Translational Research Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on
average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of PRTX-100 in Healthy Adult Volunteers
2007-06-01
2007-09-01
Completed
20
Safety of a Hypolipidemic Agent in Healthy Normal Volunteers
2007-12-01
2008-06-01
Completed
20
A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule
2009-11-23
2010-01-20
Completed
40
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
2011-08-01
2013-01-01
Completed
456
Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations
2013-10-01
2013-12-01
Completed
24
Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
2014-08-01
2015-03-01
Completed
172
Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations
2014-10-01
2014-12-01
Completed
12
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
2015-09-22
2025-09-01
Active, not recruiting
2,480
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University at Buffalo Clinical and Translational Research Center" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Intercept Pharmaceuticals" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Presidio Pharmaceuticals, Inc." with 2 trials sponsored and "Eli Lilly and Company"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University at Buffalo Clinical and Translational Research Center"
#1 collaborator was "EMD Serono" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Lantheus Medical Imaging" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "State University of New York at Buffalo" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at University at Buffalo Clinical and Translational Research Center
According to Clinical.Site data, the most researched conditions in "University at Buffalo Clinical and Translational Research Center" are
"Nonalcoholic Steatohepatitis" (4 trials), "Pharmacokinetic Assessments in Healthy Volunteers" (2 trials), "Allergy" (1 trials), "Allergy Skin" (1 trials) and "Compensated Cirrhosis" (1 trials). Many other conditions were trialed in "University at Buffalo Clinical and Translational Research Center" in a lesser frequency.
Clinical Trials Intervention Types at University at Buffalo Clinical and Translational Research Center
Most popular intervention types in "University at Buffalo Clinical and Translational Research Center" are "Drug" (12 trials), "Biological" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "PPI-668 capsule" (2 trials), "PPI-668 tablet" (2 trials), "Placebo to match SEL 18 mg" (2 trials) and "Placebo to match SEL 6 mg" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University at Buffalo Clinical and Translational Research Center
The vast majority of trials in "University at Buffalo Clinical and Translational Research Center" are
16 trials for "All" genders.
Clinical Trials Status at University at Buffalo Clinical and Translational Research Center
Currently, there are NaN active trials in "University at Buffalo Clinical and Translational Research Center".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in University at Buffalo Clinical and Translational Research Center,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in University at Buffalo Clinical and Translational Research Center, 6 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".